ERNA vs W · P/E 0.0, rev $582.0K vs rev $11.85B
Eterna Therapeutics Inc (ERNA) versus Wayfair Inc (W) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Wayfair Inc (W) is a internet retail company listed on NYSE.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported W revenue for 2024-12-31 was $11.85B. Net income was -$492.0M. Revenue was down 1.3% from 2023-12-31 to 2024-12-31. W currently screens at market cap $10.77B.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. W currently screens at market cap $10.77B.
Not investment advice. Open the ERNA and W stock pages for the full models.
Not investment advice.